Global Cancer Profiling Market size worth US$49.176 billion by 2027

Knowledge Sourcing Intelligence announces the publication of a new analysis report on the “Global Cancer Profiling Market – which is forecasted from 2020 to 2027”.

The cancer profiling market is expected to develop owing to the growing use of biomarkers in tumor profiling and the increasing worldwide prevalence of cancer. The cancer profiling market is also being driven by increased cancer research and financing activities, as well as technical advancements in profiling technology. Furthermore, throughout the projection period, the strong growth for personalized medicine and point-of-care diagnostics is anticipated to present significant potential opportunities for market competitors.

As per the report, Global Cancer Profiling Market is expected to grow at a CAGR of 15.67% to reach US$49.176 billion by 2027, from US$17.750 billion in 2020.

Cancer is characterized as uncontrolled cell proliferation with the potential to damage an individual's health. Changes in gene encoding that cause cell regulation are most commonly caused by environmental influences. Cell mutation results in abnormal cell proliferation, which affects nearby cells and organs. Cancer or tumor profiling is a diagnostic approach that examines tumor tissue samples for particular genes or gene mutations (changes), proteins, or other biomarkers. Cancer profiling can be used to help plan treatment and forecast if cancer will return or spread to other parts of the body.

However, the cancer tumor profiling market is likely to be hampered by large capital investment, expensive procedure costs, and concerns about technical challenges with sample collection and storage. Furthermore, the cancer profiling market is projected to face problems due to poor regulatory standards and reimbursement choices, as well as a low discovery-to-approval ratio.

Based on cancer type, the cancer profiling market has been segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, kidney cancer, liver cancer, and other cancers. As the number of cancer patients has increased in recent years, breast cancer profiling has become increasingly important and holds the largest market share. Breast cancer was diagnosed in about 2.3 million women worldwide, according to the WHO, with more than half a million deaths. Breast cancer dynamics are increasingly being assessed using genomics.

By application, the cancer profiling market is segmented into Personalized Medicine, Oncological Diagnostics, Cancer Research, Biomarker Discovery, Treatment & Monitoring, and others. The research applications segment is anticipated to account for the highest market share. The rapidly rising field of personalized medicine, together with the increasing focus on biomarker research for medication development, explains the substantial proportion of this market. Furthermore, rising funding for cancer research is moving the industry forward.

Based on geography segmentation, the cancer profiling market in North America is expected to increase at a steady rate over the anticipated period. According to the American Cancer Society, about 2 million new cancer cases were identified in the United States in 2021, with half a million related fatalities. The regional presence of cancer profiling will be boosted by strong government initiatives to improve cancer prevention, diagnosis, and detection. The industry's expansion will be fueled by increased research funding and investments from biotechnology and pharmaceutical businesses.

As a part of the report, the major players operating in the Global Nanocellulose market, that have been covered are Illumina, Inc., Qiagen N.V., NeoGenomics Laboratories, Inc., F. Hoffmann-La Roche Ltd, Genomic Health, GE Healthcare, Siemens Healthineers, Thermo Fisher Scientific Inc., Hologic Inc., Bio-Rad Laboratories Inc. among others.

View a sample of the report or purchase the complete study at

This analytics report segments the Global Cancer Profiling market on the following basis:

  • By Technology
    • Immunohistochemistry
    • In situ Hybridization
    • Next-Generation Sequencing
    • Quantitative Polymerase Chain Reaction (qPCR)
    • Mass Spectrometry
    • Microarrays
    • Others
  • By Cancer Type
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Melanoma Cancer
    • Kidney Cancer
    • Liver Cancer
    • Others
  • By Application
    • Personalized Medicine
    • Oncological Diagnostics
    • Cancer Research
    • Biomarker Discovery
    • Treatment & Monitoring
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others